Spending, utilization, and coverage for chronic rhinosinusitis with nasal polyposis therapies among Medicare Advantage beneficiaries-Reference-Cited by-同舟云学术

Spending, utilization, and coverage for chronic rhinosinusitis with nasal polyposis therapies among Medicare Advantage beneficiaries

Published:2024-06-25 Issue: Volume: Page:
ISSN:2042-6976
Container-title:International Forum of Allergy & Rhinology
language:en
Short-container-title:Int Forum Allergy Rhinol

Author:

Bhat Akash M.¹²^ORCID,Soler Zachary M.¹,Rathi Vinay K.¹^ORCID,Schlosser Rodney J.¹³

Affiliation:

1. Division of Rhinology and Sinus Surgery Department of Otolaryngology–Head and Neck Surgery Medical University of South Carolina Charleston South Carolina USA

2. Department of Otolaryngology‐Head and Neck Surgery Drexel University College of Medicine Philadelphia Pennsylvania USA

3. Department of Surgery Ralph H. Johnson VA Medical Center Charleston South Carolina USA

Abstract

Key points

CRSwNP‐specific mean total annual spending ranged from $5,837 (EDS‐FLU) to $28,058 (dupilumab).

Most CRSwNP patients receiving biologics had comorbid asthma and did not undergo sinus surgery.

While biologics were covered by most Medicare Part D plans, only 37% of plans covered EDS‐FLU.

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/alr.23362

Reference9 articles.

1. US Food and Drug Administration.Xhance.2023.https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209022

2. US Food and Drug Administration.Xolair.2023.https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103976

3. US Food and Drug Administration.Nucala.2023.https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761122

4. US Food and Drug Administration.Dupixent.2023.https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761055

5. Biologicals and Endoscopic Sinus Surgery for Severe Uncontrolled Chronic Rhinosinusitis With Nasal Polyps: An Economic Perspective

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Generic competition and prices for azelastine‐fluticasone nasal spray;International Forum of Allergy & Rhinology;2024-08-30